Integra LifeSciences (NASDAQ: IART) announced it has completed the submission of a Premarket Approval (PMA) Supplement application to the United ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE